However, the selective involvement of VCAM-1 across several other colonic and extracolonic disease pathologies suggests a possible functional versatility of anti-VCAM-1 antibodies that is yet to be fully explored. This evidence concerns the gene VCAM1 and glycogen storage disease VI.